listen to what mylan ceo told us yesterday about the cost of fda compliance. >> we have an unlevel playingield. it's anti-competitive and the fact governed by a 1938 law saying i shouldn't grow jobs in the united states but i'm incentivized to take my manufacturing jobs elsewhere. >> let's bring in the ceo of the generic pharmaceutical association joining us now from their annual meeting in orlando. ralph, listen, nobody's saying eliminate the fda. we have to have safe drugs, but if other countries, to heather's point, don't have the regs and cost of compliance and the drugs become commoditize as many do, how does america remain competitive? >> well, the good news, of course, is that we've got the safest drug supply in the world. further good news is that heather and all of us in the generic industry have been working with the fda on the generic drug user fee act which will provide $1.5 billion from the generics to fda so that we get our drugs approved faster. but very importantly that we have just as many inspections across the world and other facilities as we do here in the united states